PT  - JOURNAL ARTICLE
AU  - Catillon, Maryaline
AU  - Majumder, Maimuna S.
AU  - Manzi, Shannon F.
AU  - Mandl, Kenneth D.
TI  - News Coverage and Drug Shortages during the COVID-19 Pandemic
AID  - 10.1101/2020.10.12.20211656
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.12.20211656
4099  - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20211656.short
4100  - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20211656.full
AB  - Several drugs repurposed as COVID-19 treatment are in short supply. We collect data from MediaCloud and Google Health Trends about eight drugs proposed for repurposing as COVID-19 treatments and reported to be in shortage by the U.S. Food and Drug Administration (FDA) from January 1, 2020 through June 30, 2020. We find that news media coverage could have contributed to shortages due to hoarding by individuals and stockpiling by institutions, and that search trends appear to accurately discriminate between individual hoarding and institutional stockpiling.Competing Interest StatementMaryaline Catillon is an Associate at Analysis Group. The opinions expressed are those of the authors and do not necessarily reflect the views of the Analysis Group, Inc., its clients, or any of its or their respective affiliates.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available from MediaCloud and Google Health Trends.The data is available from MediaCloud and Google Health Trends.